EMERGENT BIOSOLUTIONS INC. Operating Cash Flow
EMERGENT BIOSOLUTIONS INC. (EBS) reported Operating Cash Flow of $22.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $56.10M, a 47.27% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$33.80M.
- EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $77.70M.
- EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.30M, a 101.50% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) operating activities for fiscal 2025 was $170.60M, a 190.63% increase from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) operating activities for fiscal 2024 was $58.70M.
- EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) operating activities for fiscal 2023 was -$206.30M.
- EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) operating activities for fiscal 2022 was -$34.10M, a 110.65% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $56.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $22.30M 10-Q · filed 2026-08-06 | $100.00M derived: sum of 3 quarters · filed 2026-08-06 | $97.70M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$33.80M 10-Q · filed 2026-05-01 | $43.90M derived: sum of 2 quarters · filed 2026-05-01 | $41.60M derived: sum of 3 quarters · filed 2026-05-01 | $148.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $77.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $75.40M derived: sum of 2 quarters · filed 2026-02-27 | $181.80M derived: sum of 3 quarters · filed 2026-08-06 | $170.60M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | -$2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $104.10M derived: sum of 2 quarters · filed 2026-08-06 | $92.90M 10-Q · filed 2025-10-30 | $13.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $106.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $95.20M 10-Q · filed 2026-08-06 | $15.30M derived: sum of 3 quarters · filed 2026-08-06 | $169.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$11.20M 10-Q · filed 2026-05-01 | -$91.10M derived: sum of 2 quarters · filed 2026-05-01 | $62.60M derived: sum of 3 quarters · filed 2026-05-01 | $110.10M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | -$79.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $73.80M derived: sum of 2 quarters · filed 2026-02-27 | $121.30M derived: sum of 3 quarters · filed 2026-02-27 | $58.70M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $153.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $201.20M derived: sum of 2 quarters · filed 2025-10-30 | $138.60M 10-Q · filed 2025-10-30 | $170.70M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $47.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$15.10M 10-Q · filed 2025-08-07 | $17.00M derived: sum of 3 quarters · filed 2026-02-27 | $77.00M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | -$62.60M 10-Q · filed 2025-05-08 | -$30.50M derived: sum of 2 quarters · filed 2026-02-27 | $29.50M derived: sum of 3 quarters · filed 2026-02-27 | -$84.90M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $32.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $92.10M derived: sum of 2 quarters · filed 2026-02-27 | -$22.30M derived: sum of 3 quarters · filed 2026-02-27 | -$206.30M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $60.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$54.40M derived: sum of 2 quarters · filed 2024-11-07 | -$238.40M 10-Q · filed 2024-11-07 | -$145.60M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | -$114.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$298.40M 10-Q · filed 2024-08-07 | -$205.60M derived: sum of 3 quarters · filed 2025-03-04 | -$279.60M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-03-31 | -$184.00M 10-Q · filed 2024-05-02 | -$91.20M derived: sum of 2 quarters · filed 2025-03-04 | -$165.20M derived: sum of 3 quarters · filed 2025-03-04 | -$180.80M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2022-12-31 | $92.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $18.80M derived: sum of 2 quarters · filed 2025-03-04 | $3.20M derived: sum of 3 quarters · filed 2025-03-04 | -$34.10M 10-K · filed 2025-03-04 | ||||
| 2022-09-30 | -$74.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11 | -$89.60M derived: sum of 2 quarters · filed 2023-12-11 | -$126.90M 10-Q · filed 2023-12-11 | $201.20M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-06-30 | -$15.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$52.90M 10-Q · filed 2023-08-09 | $275.20M derived: sum of 3 quarters · filed 2024-03-08 | $291.90M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | -$37.30M 10-Q · filed 2023-05-10 | $290.80M derived: sum of 2 quarters · filed 2024-03-08 | $307.50M derived: sum of 3 quarters · filed 2024-03-08 | $277.80M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $328.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $344.80M derived: sum of 2 quarters · filed 2024-03-08 | $315.10M derived: sum of 3 quarters · filed 2024-03-08 | $320.20M 10-K · filed 2024-03-08 | $321.10M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $16.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$13.00M derived: sum of 2 quarters · filed 2022-11-09 | -$7.90M 10-Q · filed 2022-11-09 | $238.10M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | -$29.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$24.60M 10-Q · filed 2022-08-02 | $221.40M derived: sum of 3 quarters · filed 2023-12-11 | $326.60M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | $5.10M 10-Q · filed 2022-04-29 | $251.10M derived: sum of 2 quarters · filed 2023-12-11 | $356.30M derived: sum of 3 quarters · filed 2023-12-11 | $484.20M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $246.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $351.20M derived: sum of 2 quarters · filed 2023-12-11 | $479.10M derived: sum of 3 quarters · filed 2023-12-11 | $536.90M 10-K/A · filed 2023-12-11 | $536.00M 10-K · filed 2021-02-19 | |||
| 2020-09-30 | $105.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $233.10M derived: sum of 2 quarters · filed 2021-11-05 | $290.90M 10-Q · filed 2021-11-05 | $413.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $127.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $185.70M 10-Q · filed 2021-07-30 | $307.80M derived: sum of 3 quarters · filed 2022-02-25 | $304.70M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $57.80M 10-Q · filed 2021-04-30 | $179.90M derived: sum of 2 quarters · filed 2022-02-25 | $176.80M derived: sum of 3 quarters · filed 2022-02-25 | $141.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $122.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $119.00M derived: sum of 2 quarters · filed 2022-02-25 | $83.20M derived: sum of 3 quarters · filed 2022-02-25 | $188.00M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | -$3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$38.90M derived: sum of 2 quarters · filed 2020-11-06 | $65.90M 10-Q · filed 2020-11-06 | -$99.90M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | -$35.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $69.00M 10-Q · filed 2020-07-31 | -$96.80M derived: sum of 3 quarters · filed 2021-02-19 | $77.20M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $104.80M 10-Q · filed 2020-05-01 | -$61.00M derived: sum of 2 quarters · filed 2021-02-19 | $113.00M derived: sum of 3 quarters · filed 2021-02-19 | $147.60M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | -$165.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $8.20M derived: sum of 2 quarters · filed 2021-02-19 | $42.80M derived: sum of 3 quarters · filed 2021-02-19 | $41.80M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $174.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $208.60M derived: sum of 2 quarters · filed 2019-11-07 | $207.60M 10-Q · filed 2019-11-07 | $207.56M 10-Q · filed 2018-11-02 | $285.09M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $34.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $33.60M 10-Q · filed 2019-08-02 | $33.59M 10-Q · filed 2018-08-03 | $111.09M derived: sum of 3 quarters · filed 2020-02-25 | $146.03M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | -$1.00M 10-Q · filed 2019-05-08 | -$991.00K 10-Q · filed 2018-05-04 | $76.49M derived: sum of 2 quarters · filed 2020-02-25 | $111.43M derived: sum of 3 quarters · filed 2020-02-25 | $165.43M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $77.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $112.43M derived: sum of 2 quarters · filed 2020-02-25 | $166.43M derived: sum of 3 quarters · filed 2020-02-25 | $208.10M 10-K · filed 2020-02-25 | $208.14M 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $34.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $88.94M derived: sum of 2 quarters · filed 2018-11-02 | $130.61M 10-Q · filed 2018-11-02 | $129.19M 10-Q · filed 2017-11-03 | $117.96M derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2017-06-30 | $54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $95.67M 10-Q · filed 2018-08-03 | $83.02M derived: sum of 3 quarters · filed 2019-02-22 | $110.10M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | $41.67M 10-Q · filed 2018-05-04 | $29.02M derived: sum of 2 quarters · filed 2019-02-22 | $56.10M derived: sum of 3 quarters · filed 2019-02-22 | |||||
| 2016-12-31 | -$12.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $14.43M derived: sum of 2 quarters · filed 2019-02-22 | $54.60M 10-K · filed 2019-02-22 | $54.62M 10-K · filed 2018-02-23 | ||||
| 2016-09-30 | $27.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $67.25M 10-Q · filed 2017-11-03 | ||||||
| 2016-06-30 | $40.17M 10-Q · filed 2017-08-04 | |||||||
| 2015-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $105.89M derived: sum of 2 quarters · filed 2018-02-23 | $108.39M derived: sum of 3 quarters · filed 2018-02-23 | $42.52M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $104.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $107.26M derived: sum of 2 quarters · filed 2015-11-06 | $41.39M 10-Q · filed 2015-11-06 | $93.21M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2015-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$63.37M 10-Q · filed 2015-08-06 | -$11.55M derived: sum of 3 quarters · filed 2015-08-06 | $67.37M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2015-03-31 | -$65.87M 10-Q · filed 2015-05-08 | -$14.05M derived: sum of 2 quarters · filed 2015-05-08 | $64.87M derived: sum of 3 quarters · filed 2015-11-06 | $75.69M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2014-12-31 | $51.82M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $130.74M derived: sum of 2 quarters · filed 2015-11-06 | $141.56M derived: sum of 3 quarters · filed 2015-11-06 | $112.32M 10-K · filed 2015-03-09 | ||||
| 2014-09-30 | $78.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $89.74M derived: sum of 2 quarters · filed 2015-11-06 | $60.50M 10-Q · filed 2015-11-06 | $69.14M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2014-06-30 | $10.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$18.43M 10-Q · filed 2015-08-06 | -$9.79M derived: sum of 3 quarters · filed 2015-08-06 | $50.34M derived: sum of 4 quarters · filed 2015-08-06 | ||||
| 2014-03-31 | -$29.25M 10-Q · filed 2015-05-08 | -$20.60M derived: sum of 2 quarters · filed 2015-05-08 | $39.52M derived: sum of 3 quarters · filed 2015-05-08 | $72.35M derived: sum of 4 quarters · filed 2015-05-08 | ||||
| 2013-12-31 | $8.64M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $68.77M derived: sum of 2 quarters · filed 2015-03-09 | $101.59M derived: sum of 3 quarters · filed 2015-03-09 | $96.97M 10-K · filed 2015-03-09 | ||||
| 2013-09-30 | $60.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $92.95M derived: sum of 2 quarters · filed 2014-11-10 | $88.33M 10-Q · filed 2014-11-10 | $49.31M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | $32.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $28.20M 10-Q · filed 2014-08-08 | -$10.82M derived: sum of 3 quarters · filed 2015-03-09 | $35.67M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | -$4.63M 10-Q · filed 2014-05-12 | -$43.65M derived: sum of 2 quarters · filed 2015-03-09 | $2.84M derived: sum of 3 quarters · filed 2015-03-09 | $21.18M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | -$39.02M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $7.46M derived: sum of 2 quarters · filed 2015-03-09 | $25.80M derived: sum of 3 quarters · filed 2015-03-09 | $39.64M 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $46.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $64.82M derived: sum of 2 quarters · filed 2013-11-08 | $78.66M 10-Q · filed 2013-11-08 | $81.63M 10-Q · filed 2012-11-01 | $115.59M derived: sum of 4 quarters · filed 2014-03-10 | |||
| 2012-06-30 | $18.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $32.18M 10-Q · filed 2013-08-06 | $34.73M 10-Q · filed 2012-08-03 | $69.11M derived: sum of 3 quarters · filed 2014-03-10 | $73.77M derived: sum of 4 quarters · filed 2014-03-10 | |||
| 2012-03-31 | $13.84M 10-Q · filed 2013-05-03 | $15.82M 10-Q · filed 2012-05-04 | $50.77M derived: sum of 2 quarters · filed 2014-03-10 | $55.43M derived: sum of 3 quarters · filed 2014-03-10 | $48.75M derived: sum of 4 quarters · filed 2014-03-10 | |||
| 2011-12-31 | $36.93M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $41.59M derived: sum of 2 quarters · filed 2014-03-10 | $34.91M derived: sum of 3 quarters · filed 2014-03-10 | $12.19M 10-K · filed 2014-03-10 | $14.59M 10-K · filed 2012-03-09 | |||
| 2011-09-30 | $4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$2.02M derived: sum of 2 quarters · filed 2012-11-01 | -$24.75M 10-Q · filed 2012-11-01 | -$23.97M 10-Q · filed 2011-11-04 | -$2.09M derived: sum of 4 quarters · filed 2013-03-08 | |||
| 2011-06-30 | -$6.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$29.41M 10-Q · filed 2012-08-03 | -$28.81M 10-Q · filed 2011-08-05 | -$6.75M derived: sum of 3 quarters · filed 2013-03-08 | $47.42M derived: sum of 4 quarters · filed 2013-03-08 | |||
| 2011-03-31 | -$22.72M 10-Q · filed 2012-05-04 | -$67.00K derived: sum of 2 quarters · filed 2013-03-08 | $54.10M derived: sum of 3 quarters · filed 2013-03-08 | |||||
| 2010-12-31 | $22.66M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $76.83M derived: sum of 2 quarters · filed 2013-03-08 | $98.02M 10-K · filed 2013-03-08 | $98.93M 10-K · filed 2012-03-09 | ||||
| 2010-09-30 | $54.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $75.36M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | $21.19M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $29.87M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |